Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up 0.45% Nasdaq Up 0.29%
Streaming
Ticker Tape: On

Rydex Biotechnology Inv (RYOIX)

53.64 Down 0.61(1.12%) May 20

Prev Close:53.64
YTD Return*:9.73%
Net Assets*:192.74M
Yield*:N/A

* As of 28-Feb-13

Quotes delayed, except where indicated otherwise. Currency in USD.

Top Holdings

Symbol% AssetsYTD Return %
AMGN8.007.95
GILD7.9818.31
CELG7.2534.60
BIIB6.2015.26
ALXN4.27-7.44
» More Fund Holdings

Fund Basics

Morningstar Overall Rating:
Total Assets:192.74M
Category:Health
Annual Report Expense Ratio (net):1.36%
Fund Profile | Holdings

Performance & Risk

YTD Return:9.73%
5y Avg Return:16.27%
Rank in Category (ytd):21
% Rank in Category (ytd):15%
Beta (3y):0.90
Morningstar Risk Rating:4
Performance Details | Risk Details

Fund Summary

The investment seeks capital appreciation. The fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It will invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified. View More
Fund Profile
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback